Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Bladder Cancer, January 2014

Free Subscription


Retrieve all available abstracts of the following 282 articles:
HTML format


Single Articles

  1. HOSEN MB, Islam J, Salam MA, Islam MF, et al
    N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.
    Asia Pac J Clin Oncol. 2014 Nov 6. doi: 10.1111/ajco.12291.
    Abstract     Related articles   

  2. YE F, Wang L, Castillo-Martin M, McBride R, et al
    Biomarkers for bladder cancer management: present and future.
    Am J Clin Exp Urol. 2014;2:1-14.
    Abstract     Related articles   

  3. LEE JH, Song HR, Kim HN, Kweon SS, et al
    Genetic Variation in PSCA is Associated with Bladder Cancer Susceptibility in a Korean Population.
    Asian Pac J Cancer Prev. 2014;15:8901-4.
    Abstract     Related articles   

  4. WANG X, Cheng H, Chen Y, Li H, et al
    [Expression of IkappaBalpha in bladder cancer cell lines is negatively correlated with epithelial-mesenchymal transition and cell invasion in vitro].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014;30:1159-61.
    Abstract     Related articles   

  5. LIU Y, Zeng Y, Liu L, Zhuang C, et al
    Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells.
    Nat Commun. 2014;5:5393.
    Abstract     Related articles   

  6. CAILLET P, Mongiat-Artus P, Liuu E, Dutendas S, et al
    [Kidney and bladder cancers in the elderly].
    Soins Gerontol. 2014;:38-42.
    Abstract     Related articles   

  7. ALI AM, Nelvigi GG, Keshavaiah VG, Ratkal CS, et al
    Extensive xanthogranulomatous cystitis mimicking bladder cancer.
    Urol Ann. 2014;6:373-5.
    Abstract     Related articles   

  8. GILL TS, Das RK, Basu S, Dey RK, et al
    Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer.
    Urol Ann. 2014;6:305-8.
    Abstract     Related articles   

  9. AL-MANSOUR M, Saadeddin A, Alkhateeb S, Abusamra A, et al
    Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer.
    Urol Ann. 2014;6:273-7.
    Abstract     Related articles   

  10. SHEN M, Duan X, Zhou P, Zhou W, et al
    Lymphotoxin beta receptor activation promotes bladder cancer in a nuclear factor-kappaB-dependent manner.
    Mol Med Rep. 2014 Oct 30. doi: 10.3892/mmr.2014.2826.
    Abstract     Related articles   

  11. The NOTCH Pathway Plays a Tumor Suppressive Role in Bladder Cancer.
    Cancer Discov. 2014;4:1252.
    Abstract     Related articles   

  12. LIU L, Qiu M, Tan G, Liang Z, et al
    miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
    J Transl Med. 2014;12:305.
    Abstract     Related articles   

    Bladder cancer: Measuring response to treatment.
    Nat Rev Urol. 2014 Nov 4. doi: 10.1038/nrurol.2014.
    Abstract     Related articles   

  14. KRISHNATREYA M, Saikia A, Kataki A, Sharma J, et al
    Variations in the spatial distribution of gall bladder cancer: a call for collaborative action.
    Ann Med Health Sci Res. 2014;4.
    Abstract     Related articles   

  15. YOSHIDA T, Okuyama H, Nakayama M, Endo H, et al
    High-dose chemotherapeutics of intravesical chemotherapy rapidly induce mitochondrial dysfunction in bladder cancer-derived spheroids.
    Cancer Sci. 2014 Nov 1. doi: 10.1111/cas.12567.
    Abstract     Related articles   

  16. TAI YS, Chen CH, Huang CY, Tai HC, et al
    Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma.
    Diabetes Metab Res Rev. 2014 Nov 3. doi: 10.1002/dmrr.2614.
    Abstract     Related articles   

  17. EIFLER JB, Barocas DA, Resnick MJ
    Predictors of outcome in bladder cancer.
    J Natl Compr Canc Netw. 2014;12:1549-54.
    Abstract     Related articles   

  18. LIAO Y, Huang JL, Qiu MX, Ma ZW, et al
    Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis.
    Tumour Biol. 2014.
    Abstract     Related articles   

  19. ZHANG K, Zhou B, Zhang P, Zhang Z, et al
    Prognostic value of serum nicotinamide phosphoribosyltransferase in patients with bladder cancer.
    Croat Med J. 2014;55:507-13.
    Abstract     Related articles   

  20. BJURLIN MA, Zhao LC, Huang WC
    More on robot-assisted laparoscopic radical cystectomy.
    N Engl J Med. 2014;371:1654-5.
    Abstract     Related articles   

  21. BOCHNER BH, Laudone VP
    More on robot-assisted laparoscopic radical cystectomy.
    N Engl J Med. 2014;371:1655.
    Abstract     Related articles   

  22. LI Z, Li X, Wu S, Xue M, et al
    Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway.
    Cancer Sci. 2014;105:951-5.
    Abstract     Related articles   

  23. SKELDON SC, Goldenberg SL
    Urological complications of illicit drug use.
    Nat Rev Urol. 2014;11:169-77.
    Abstract     Related articles   

  24. BALAR AV
    The impact of taxanes on the management of genitourinary cancers.
    Anticancer Drugs. 2014;25:555-60.
    Abstract     Related articles   

  25. MAYR R, Fritsche HM, Pycha A, Pycha A, et al
    Radical cystectomy and the implications of comorbidity.
    Expert Rev Anticancer Ther. 2014;14:289-95.
    Abstract     Related articles   

  26. AGARWAL N, Bellmunt J, Maughan BL, Boucher KM, et al
    Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma.
    Clin Genitourin Cancer. 2014;12:130-7.
    Abstract     Related articles   

  27. HUYNH K, Krantz J, Ahmadi N, Indrajit B, et al
    A case of peritoneal mesothelioma masquerading as a urachal mass.
    ANZ J Surg. 2014;84:185-6.
    Abstract     Related articles   

  28. HAGHIGHITALAB A, Matin MM, Bahrami AR, Iranshahi M, et al
    Enhancement of cisplatin cytotoxicity in combination with herniarin in vitro.
    Drug Chem Toxicol. 2014;37:156-62.
    Abstract     Related articles   

  29. KRAMER MW, Heinisch A, Wegener G, Abbas M, et al
    [C-reactive protein prior to radical cystectomy: preoperative determination of CRP].
    Urologe A. 2014;53:222-7.
    Abstract     Related articles   

  30. KO H, Park SY, Cha EJ, Sohn JS, et al
    Primary small cell carcinoma of the urinary bladder: a case report demonstrates cytological findings in SurePath liquid-based cytology.
    Cytopathology. 2014;25:135-6.
    Abstract     Related articles   

  31. SMITH PJ, Lotan Y, Raj GV, Sagalowsky AI, et al
    Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
    Cytopathology. 2014;25:108-11.
    Abstract     Related articles   

  32. CHAWKI S, Ploussard G, Montlahuc C, Verine J, et al
    Bladder cancer in HIV-infected adults: an emerging concern?
    J Int AIDS Soc. 2014;17.
    Abstract     Related articles   

  33. KUMAGAI J, Matsushima H, Murayama S, Yokoyama M, et al
    [A Case of Bladder Cancer Arising after Augmentation Cystoplasty Using Ileal Patch for Interstitial Cystitis.]
    Hinyokika Kiyo. 2014;60:513-515.
    Abstract     Related articles   

  34. UEDA N, Kawamura M, Nakazawa S, Hirai T, et al
    [Complete Atrioventricular Block Due to Cardiac Metastasis from Bladder Cancer : Case Report.]
    Hinyokika Kiyo. 2014;60:501-506.
    Abstract     Related articles   

  35. THOMPSON DB, Siref LE, Feloney MP, Hauke RJ, et al
    Immunological basis in the pathogenesis and treatment of bladder cancer.
    Expert Rev Clin Immunol. 2014.
    Abstract     Related articles   

  36. MAMTANI R, Haynes K, Boursi B, Scott FI, et al
    Validation of a coding algorithm to identify bladder cancer and distinguish stage in an electronic medical records database.
    Cancer Epidemiol Biomarkers Prev. 2014 Nov 11. pii: cebp.0677.2014.
    Abstract     Related articles   

  37. JIN D, Cao M, Mu X, Yang G, et al
    Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
    Cell Biochem Biophys. 2014.
    Abstract     Related articles   

  38. CHAN EC, Pasikanti KK, Hong Y, Ho PC, et al
    Metabonomic profiling of bladder cancer.
    J Proteome Res. 2014.
    Abstract     Related articles   

  39. WANG W, Zhu H, Zhang H, Zhang L, et al
    Targeting PPM1D by lentivirus-mediated RNA interference inhibits the tumorigenicity of bladder cancer cells.
    Braz J Med Biol Res. 2014;47:1044-9.
    Abstract     Related articles   

  40. ZHANG G, Gomes-Giacoia E, Dai Y, Lawton A, et al
    Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature.
    Diagn Pathol. 2014;9:200.
    Abstract     Related articles   

  41. AL-TARTIR T, Raza SJ, Alotaibi M, Khan A, et al
    Robot-assisted surgical approach to bladder cancer: a decade of progress!
    Minerva Urol Nefrol. 2014.
    Abstract     Related articles   

  42. Bladder cancer: DeltaNp63 is a favourable prognostic factor.
    Nat Rev Urol. 2014 Nov 11. doi: 10.1038/nrurol.2014.
    Abstract     Related articles   

  43. KRAJEWSKI W, Piszczek R, Krajewska M, Dembowski J, et al
    Urinary diversion metabolic complications - underestimated problem.
    Adv Clin Exp Med. 2014;23:633-8.
    Abstract     Related articles   

  44. MCDANIEL AS, Zhai Y, Cho KR, Dhanasekaran SM, et al
    HRAS mutations are frequent in inverted urothelial neoplasms.
    Hum Pathol. 2014;45:1957-65.
    Abstract     Related articles   

  45. SONG Y, Yang L, Zhou A, Chi Y, et al
    [Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder].
    Zhonghua Zhong Liu Za Zhi. 2014;36:212-6.
    Abstract     Related articles   

  46. TZORTZIS V, Dimitropoulos K, Gravas S, Karatzas A, et al
    The impact of stapling devices use on patients with increased body mass index treated with radical cystectomy.
    Can J Urol. 2014;21:7114-9.
    Abstract     Related articles   

  47. GANDAGLIA G, Varda B, Sood A, Pucheril D, et al
    Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database.
    Can Urol Assoc J. 2014;8.
    Abstract     Related articles   

  48. HSU T, Black PC, Chi KN, Canil CM, et al
    Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists.
    Can Urol Assoc J. 2014;8.
    Abstract     Related articles   

  49. BOOTH CM, Siemens DR
    Delivering high-quality care to patients with muscle-invasive bladder cancer: Insights from routine practice in Ontario.
    Can Urol Assoc J. 2014;8.
    Abstract     Related articles   

  50. STANESCU F, Geavlete B, Georgescu D, Jecu M, et al
    NBI - plasma vaporization hybrid approach in bladder cancer endoscopic management.
    J Med Life. 2014;7:155-159.
    Abstract     Related articles   

  51. MEDIAVILLA E, Portillo JA, Truan D, Campos-Juanatey F, et al
    Predictive factors of evolution of patients after pT0 radical cystectomy due to bladder cancer.
    Arch Esp Urol. 2014;67:764-769.
    Abstract     Related articles   

  52. TEPLY BA, Kim JJ
    Systemic therapy for bladder cancer - a medical oncologist's perspective.
    J Solid Tumors. 2014;4:25-35.
    Abstract     Related articles   

  53. STONE L
    Bladder cancer: On the dot-targeted molecular imaging.
    Nat Rev Urol. 2014 Nov 18. doi: 10.1038/nrurol.2014.
    Abstract     Related articles   

  54. JIN H, Yu Y, Hu Y, Lu C, et al
    Divergent behaviors and underlying mechanisms of cell migration and invasion in non-metastatic T24 and its metastatic derivative T24T bladder cancer cell lines.
    Oncotarget. 2014.
    Abstract     Related articles   

  55. LI LJ, Zhu JL, Bao WS, Chen DK, et al
    Long noncoding RNA GHET1 promotes the development of bladder cancer.
    Int J Clin Exp Pathol. 2014;7:7196-205.
    Abstract     Related articles   

  56. CEGAN M, Kolostova K, Matkowski R, Broul M, et al
    In vitro culturing of viable circulating tumor cells of urinary bladder cancer.
    Int J Clin Exp Pathol. 2014;7:7164-71.
    Abstract     Related articles   

  57. LI J, Wang Q, Xiao B, Zhang X, et al
    Effect of internal iliac artery chemotherapy after transurethral resection of bladder tumor for muscle invasive bladder cancer.
    Chin J Cancer Res. 2014;26:558-63.
    Abstract     Related articles   

  58. PEREZ-JACOISTE ASIN MA, Fernandez-Ruiz M, Lopez-Medrano F, Lumbreras C, et al
    Bacillus Calmette-Guerin (BCG) Infection Following Intravesical BCG Administration as Adjunctive Therapy For Bladder Cancer: Incidence, Risk Factors, and Outcome in a Single-Institution Series and Review of the Literature.
    Medicine (Baltimore). 2014;93:236-54.
    Abstract     Related articles   

  59. KIM CY, Lee SW, Yoon G, Jeong SY, et al
    Incidental detection of increased F-FDG uptake and its follow-up in patients with granulomatous prostatitis after BCG treatment for urinary bladder cancer.
    Hell J Nucl Med. 2014 Nov 12. pii: s002449910146.
    Abstract     Related articles   

  60. MIAO L, Guo S, Zhang J, Kim WY, et al
    Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer.
    Adv Funct Mater. 2014;24:6601-6611.
    Abstract     Related articles   

  61. BEUKERS W, Kandimalla R, Masius RG, Vermeij M, et al
    Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer.
    Mod Pathol. 2014 Nov 14. doi: 10.1038/modpathol.2014.
    Abstract     Related articles   

  62. CHUANG JJ, Dai YC, Lin YL, Chen YY, et al
    Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis.
    Toxicol Appl Pharmacol. 2014;279:322-30.
    Abstract     Related articles   

  63. LOPEZ DE MATURANA E, Ibanez-Escriche N, Gonzalez-Recio O, Marenne G, et al
    Next generation modeling in GWAS: comparing different genetic architectures.
    Hum Genet. 2014;133:1235-53.
    Abstract     Related articles   

  64. GHOSH M, Brancato SJ, Agarwal PK, Apolo AB, et al
    Targeted therapies in urothelial carcinoma.
    Curr Opin Oncol. 2014;26:305-20.
    Abstract     Related articles   

  65. ZHENG X, Ou Y, Shu M, Wang Y, et al
    Cholera toxin, a typical protein kinase A activator, induces G1 phase growth arrest in human bladder transitional cell carcinoma cells via inhibiting the c-Raf/MEK/ERK signaling pathway.
    Mol Med Rep. 2014;9:1773-9.
    Abstract     Related articles   

  66. BASIRI A, Shakhssalim N, Jalaly NY, Miri HH, et al
    Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran.
    Asian Pac J Cancer Prev. 2014;15:1459-63.
    Abstract     Related articles   

  67. OZBEK E, Otunctemur A, Dursun M, Koklu I, et al
    Association between the metabolic syndrome and high tumor grade and stage of primary urothelial cell carcinoma of the bladder.
    Asian Pac J Cancer Prev. 2014;15:1447-51.
    Abstract     Related articles   

  68. TEKGUL ZT, Divrik RT, Turan M, Konyalioglu E, et al
    Impact of obturator nerve block on the short-term recurrence of superficial bladder tumors on the lateral wall.
    Urol J. 2014;11:1248-52.
    Abstract     Related articles   

  69. JAMSHIDIAN H, Hashemi M, Nowroozi MR, Ayati M, et al
    Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder transitional cell carcinoma.
    Urol J. 2014;11:1232-7.
    Abstract     Related articles   

  70. WANG XB, Lin YL, Li ZG, Ma JH, et al
    Protocadherin 17 promoter methylation in tumour tissue from patients with bladder transitional cell carcinoma.
    J Int Med Res. 2014;42:292-9.
    Abstract     Related articles   

  71. GIONFRIDDO MR, Morey-Vargas OL, Brito JP, Leppin AL, et al
    Systematic reviews to ascertain the safety of diabetes medications.
    Curr Diab Rep. 2014;14:478.
    Abstract     Related articles   

  72. RAUSCH S, Gaisa N, Youssef RF, Lotan Y, et al
    [Squamous cell lesions of the urinary bladder].
    Urologe A. 2014;53:368.
    Abstract     Related articles   

  73. BRUNKEN C, Tauber S, Wohlmuth P
    [Morbidity, mortality, and overall survival after radical cystectomy: comparison of single-center results with the literature and a nomogram].
    Urologe A. 2014;53:362.
    Abstract     Related articles   

  74. ROUANNE M, Legrand G, Neuzillet Y, Ghoneim T, et al
    Long-term women-reported quality of life after radical cystectomy and orthotopic ileal neobladder reconstruction.
    Ann Surg Oncol. 2014;21:1398-404.
    Abstract     Related articles   

  75. HU Z, Mudaliar K, Quek ML, Paner GP, et al
    Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.
    Ann Diagn Pathol. 2014;18:49-52.
    Abstract     Related articles   

  76. SPEICHER PJ, Turley RS, Sloane JL, Mantyh CR, et al
    Pelvic exenteration for the treatment of locally advanced colorectal and bladder malignancies in the modern era.
    J Gastrointest Surg. 2014;18:782-8.
    Abstract     Related articles   

  77. CUSSENOT O, Sighar K, Mohammed M, Hugonin S, et al
    Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma.
    World J Urol. 2014;32:551-7.
    Abstract     Related articles   

  78. ZOU L, Zhang L, Zhang H, Jiang H, et al
    Comparison of post-operative intravesical recurrence and oncological outcomes after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    World J Urol. 2014;32:565-70.
    Abstract     Related articles   

  79. PLOUSSARD G, Albrand G, Rozet F, Lang H, et al
    Challenging treatment decision-making in older urologic cancer patients.
    World J Urol. 2014;32:299-308.
    Abstract     Related articles   

  80. PALOU-REDORTA J, Roupret M, Gallagher JR, Heap K, et al
    The use of immediate postoperative instillations of intravesical chemotherapy after TURBT of NMIBC among European countries.
    World J Urol. 2014;32:525-30.
    Abstract     Related articles   

  81. HOLMANG S, Johansson SL
    Long-term follow-up of patients with tumours of the renal pelvis and ureter: how often is a bladder tumour diagnosed after five tumour-free years?
    Scand J Urol. 2014;48:65-72.
    Abstract     Related articles   

  82. AAGAARD MF, Mogensen K, Hermann GG
    Delayed healing at transurethral resection of bladder tumour sites after immediate postoperative mitomycin C instillation.
    Scand J Urol. 2014;48:222-4.
    Abstract     Related articles   

  83. PAANANEN I, Ohtonen P, Perttila I, Jonsson O, et al
    Functional results after orthotopic bladder substitution: a prospective multicentre study comparing four types of neobladder.
    Scand J Urol. 2014;48:90-8.
    Abstract     Related articles   

  84. SPRINGER C, Mohammed N, Alba S, Theil G, et al
    Laparoscopic radical cystectomy with extracorporeal ileal neobladder for muscle-invasive urothelial carcinoma of the bladder: technique and short-term outcomes.
    World J Urol. 2014;32:407-12.
    Abstract     Related articles   

  85. EVERS PD, Logan JE, Sills V, Chin AI, et al
    Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    World J Urol. 2014;32:385-91.
    Abstract     Related articles   

  86. GIERTH M, Fritsche HM, Buchner H, May M, et al
    Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.
    World J Urol. 2014;32:365-71.
    Abstract     Related articles   

  87. BOURGADE V, Drouin SJ, Yates DR, Parra J, et al
    Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival.
    World J Urol. 2014;32:475-9.
    Abstract     Related articles   

  88. CHOI JW, Kim Y, Lee JH, Kim YS, et al
    Expression of beta-tubulin isotypes in urothelial carcinoma of the bladder.
    World J Urol. 2014;32:347-52.
    Abstract     Related articles   

  89. POWLES T, Eder JP, Fine GD, Braiteh FS, et al
    MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.
    Nature. 2014;515:558-62.
    Abstract     Related articles   

  90. GOGALIC S, Sauer U, Doppler S, Preininger C, et al
    Bladder cancer biomarker array to detect aberrant levels of proteins in urine.
    Analyst. 2014.
    Abstract     Related articles   

  91. TSAO CK, Liaw B, Oh WK, Galsky MD, et al
    Muscle invasive bladder cancer: closing the gap between practice and evidence.
    Minerva Urol Nefrol. 2014.
    Abstract     Related articles   

  92. SINGH V, Mandal S, Patil S, Sinha RJ, et al
    Urodynamic and continence assessment of orthotropic neobladder reconstruction following radical cystectomy in bladder cancer; a prospective, blinded North Indian tertiary care experience.
    South Asian J Cancer. 2014;3:223-226.
    Abstract     Related articles   

  93. QIN X, Wu K, Xie L, Zhao S, et al
    Reduced dose of Bacillus Calmette-Guerin versus full dose of Bacillus Calmette-Guerin for non-muscle-invasive bladder cancer after transurethral resection bladder tumor: a meta-analysis of randomized controlled trials.
    Chin Med J (Engl). 2014;127:3970-4.
    Abstract     Related articles   

  94. SEIDEMAN C, Canter D, Kim P, Cordon B, et al
    Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?
    World J Urol. 2014.
    Abstract     Related articles   

  95. LIN J, Blalock JA, Chen M, Ye Y, et al
    Depressive Symptoms and Short Telomere Length Are Associated with Increased Mortality in Bladder Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2014 Nov 21. pii: cebp.0992.2014.
    Abstract     Related articles   

  96. CHEN XN, Wang KF, Xu ZQ, Li SJ, et al
    MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1.
    Cancer Cell Int. 2014;14:70.
    Abstract     Related articles   

  97. AGHION DM, Capek S, Howe BM, Hepel JT, et al
    Erratum to: Perineural tumor spread of bladder cancer causing lumbosacral plexopathy: an anatomic explanation.
    Acta Neurochir (Wien). 2014.
    Abstract     Related articles   

  98. HUANG K, Chen G, Luo J, Zhang Y, et al
    Clinicopathological and cellular signature of PAK1 in human bladder cancer.
    Tumour Biol. 2014.
    Abstract     Related articles   

  99. AMIN MB, Smith SC, Reuter VE, Epstein JI, et al
    Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.
    Mod Pathol. 2014 Nov 21. doi: 10.1038/modpathol.2014.
    Abstract     Related articles   

  100. ZHAO F, Lin T, He W, Han J, et al
    Knockdown of a novel LincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer.
    Oncotarget. 2014.
    Abstract     Related articles   

  101. SHEN Y, Bu M, Zhang A, Liu Y, et al
    Toll-like receptor 4 gene polymorphism downregulates gene expression and involves in susceptibility to bladder cancer.
    Tumour Biol. 2014.
    Abstract     Related articles   

  102. RYDER RE
    Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit.
    Diabet Med. 2014 Dec 3. doi: 10.1111/dme.12627.
    Abstract     Related articles   

  103. KOIE T, Ohyama C, Yamamoto H, Imai A, et al
    Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.
    Med Oncol. 2015;32:421.
    Abstract     Related articles   

  104. SANTOS F, Zakaria AS, Kassouf W, Tanguay S, et al
    High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec.
    World J Urol. 2014.
    Abstract     Related articles   

  105. KURTOVA AV, Xiao J, Mo Q, Pazhanisamy S, et al
    Blocking PGE-induced tumour repopulation abrogates bladder cancer chemoresistance.
    Nature. 2014 Dec 3. doi: 10.1038/nature14034.
    Abstract     Related articles   

  106. CHEN RC
    Organ Preservation - Will Data Translate into Reality for Bladder Cancer Patients?
    Clin Oncol (R Coll Radiol). 2014 Nov 24. pii: S0936-6555(14)00418.
    Abstract     Related articles   

  107. IULIANO JN, Kutscha PD, Biderman N, Subbaram S, et al
    Metastatic bladder cancer cells distinctively sense and respond to physical cues of collagen fibril-mimetic nanotopography.
    Exp Biol Med (Maywood). 2014 Dec 2. pii: 1535370214560973.
    Abstract     Related articles   

  108. ZOU J, Han Z, Zhou L, Cai C, et al
    Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer.
    Med Oncol. 2015;32:373.
    Abstract     Related articles   

  109. VIEIRA AR, Vingeliene S, Chan DS, Aune D, et al
    Fruits, vegetables, and bladder cancer risk: a systematic review and meta-analysis.
    Cancer Med. 2014 Dec 2. doi: 10.1002.
    Abstract     Related articles   

  110. CHEN HC, Chen YT, Tsai RY, Chen MC, et al
    A sensitive and selective magnetic graphene composite-modified polycrystalline-silicon nanowire field-effect transistor for bladder cancer diagnosis.
    Biosens Bioelectron. 2014;66C:198-207.
    Abstract     Related articles   

  111. MONN MF, Kaimakliotis HZ, Pedrosa JA, Cary KC, et al
    Contemporary bladder cancer: Variant histology may be a significant driver of disease.
    Urol Oncol. 2014 Nov 1. pii: S1078-1439(14)00342.
    Abstract     Related articles   

  112. DI PAOLO PL, Vargas HA, Karlo CA, Lakhman Y, et al
    Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes.
    Clin Imaging. 2014 Oct 16. pii: S0899-7071(14)00235.
    Abstract     Related articles   

  113. KANATANI A, Nakagawa T, Kawai T, Naito A, et al
    Adjuvant Chemotherapy Is Possibly Beneficial for Locally Advanced or Node-Positive Bladder Cancer.
    Clin Genitourin Cancer. 2014 Nov 6. pii: S1558-7673(14)00214.
    Abstract     Related articles   

  114. LIN R, Shen W, Zhi Y, Zhou Z, et al
    Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer.
    Biomed Pharmacother. 2014 Oct 14. pii: S0753-3322(14)00129.
    Abstract     Related articles   

  115. BELLEFQIH S, Khalil J, Mezouri I, ElKacemi H, et al
    [Concomitant chemoradiotherapy for muscle-invasive bladder cancer: Current knowledge, controversies and future directions.]
    Cancer Radiother. 2014 Nov 1. pii: S1278-3218(14)00360.
    Abstract     Related articles   

  116. HUANG P, Ma C, Xu P, Guo K, et al
    Efficacy of intravesical Bacillus Calmette-Guerin therapy against tumor immune escape in an orthotopic model of bladder cancer.
    Exp Ther Med. 2015;9:162-166.
    Abstract     Related articles   

  117. FARFARIELLO V, Liberati S, Morelli MB, Tomassoni D, et al
    Resiniferatoxin induces death of bladder cancer cells associated with mitochondrial dysfunction and reduces tumor growth in a xenograft mouse model.
    Chem Biol Interact. 2014;224C:128-135.
    Abstract     Related articles   

  118. KANG Z, Li Y, Yu Y, Guo Z, et al
    Research progress on bladder cancer molecular genetics.
    J Cancer Res Ther. 2014;10 Suppl:C89-94.
    Abstract     Related articles   

  119. WANG C, Chen Z, Ge Q, Hu J, et al
    Up-regulation of p21 by miRNAs and its implications in bladder cancer cells.
    FEBS Lett. 2014 Nov 11. pii: S0014-5793(14)00786.
    Abstract     Related articles   

  120. GOFRIT ON, Nof R, Meirovitz A, Pode D, et al
    Radical cystectomy vs. chemoradiation in T2-4aN0M0 bladder cancer: A case-control study.
    Urol Oncol. 2014 Nov 4. pii: S1078-1439(14)00334.
    Abstract     Related articles   

  121. LV L, Li Y, Deng H, Zhang C, et al
    MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene.
    Cancer Lett. 2014 Nov 11. pii: S0304-3835(14)00656.
    Abstract     Related articles   

  122. DINNEY CP, Hansel D, McConkey D, Shipley W, et al
    Novel neoadjuvant therapy paradigms for bladder cancer: Results from the National Cancer Center Institute Forum.
    Urol Oncol. 2014 Oct 24. pii: S1078-1439(14)00025.
    Abstract     Related articles   

  123. SCHMIDT S, Frances A, Lorente Garin JA, Juanpere N, et al
    Quality of life in patients with non-muscle-invasive bladder cancer: One-year results of a multicentre prospective cohort study.
    Urol Oncol. 2014 Oct 22. pii: S1078-1439(14)00325.
    Abstract     Related articles   

  124. CHAMIE K, Ballon-Landa E, Daskivich TJ, Bassett JC, et al
    Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer.
    Urol Oncol. 2014 Nov 7. pii: S1078-1439(14)00294.
    Abstract     Related articles   

  125. FURBERG H, Schoenberg M
    The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.
    Urol Oncol. 2014 Nov 6. pii: S1078-1439(14)00324.
    Abstract     Related articles   

    Commentary on "Economic and humanistic consequences of preventable bladder tumor recurrences in nonmuscle invasive bladder cancer cases." Lee CT, Barocas D, Globe DR, Oefelein MG, Colayco DC, Bruno A, ODay K, Bramley T, Department of Urology, Universi
    Urol Oncol. 2014;32:1089.
    Abstract     Related articles   

  127. NAWROTH R, Goebell PJ, Kamat AM, Kiemeney LA, et al
    Current concepts-Future needs: The 10th Annual Meeting of the International Bladder Cancer Network (IBCN) in Nijmegen, The Netherlands, September 20th to 22nd, 2012.
    Urol Oncol. 2014;32:1049-1050.
    Abstract     Related articles   

  128. SUN M, Zhao W, Xie Q, Zhan Y, et al
    Lentinan reduces tumor progression by enhancing gemcitabine chemotherapy in urothelial bladder cancer.
    Surg Oncol. 2014 Nov 20. pii: S0960-7404(14)00083.
    Abstract     Related articles   

  129. HEVER NV, Pentek M, Ballo A, Gulacsi L, et al
    Health Related Quality of Life in Patients with Bladder Cancer: A Cross-Sectional Survey and Validation Study of the Hungarian Version of the Bladder Cancer Index.
    Pathol Oncol Res. 2014.
    Abstract     Related articles   

  130. TANG SH, Huang HS, Wu HU, Tsai YT, et al
    Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo.
    Oncotarget. 2014;5:10342-55.
    Abstract     Related articles   

  131. VAN RHIJN BW, Musquera M, Liu L, Vis AN, et al
    Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications.
    Mod Pathol. 2014 Nov 28. doi: 10.1038/modpathol.2014.
    Abstract     Related articles   

  132. TALUKDAR S, Emdad L, Das SK, Sarkar D, et al
    Noninvasive approaches for detecting and monitoring bladder cancer.
    Expert Rev Anticancer Ther. 2014.
    Abstract     Related articles   

  133. SEE WA
    Commentary on "Outpatient laser ablation of non-muscle-invasive bladder cancer: Is it safe, tolerable and cost-effective?" Wong KA, Zisengwe G, Athanasiou T, OBrien T, Thomas K, The Urology Centre, Guys and St. Thomas' NHS Foundation Trust.: BJU Int 2
    Urol Oncol. 2014;32:1350-1.
    Abstract     Related articles   

  134. SEE WA
    Commentary on "Optimal schedule of bacillus Calmette-Guerin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies." Zhu S, Tang Y, Li K, Shang Z, Jiang N, Nian X, Sun L, Niu Y, Department of Urology Tianjin Institute of Urolog
    Urol Oncol. 2014;32:1349-50.
    Abstract     Related articles   

  135. KAMAT A
    Commentary on "Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed fornonmuscle invasive bladder cancer." Sternberg IA, Chen LY, Herr HW, Donat SM, Bochner BH, Dalbagni G, Urology Service, Depart
    Urol Oncol. 2014;32:1348-9.
    Abstract     Related articles   

  136. ONAL B, Han U, Yilmaz S, Koybasioglu F, et al
    The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer-institutional experience and review.
    Diagn Cytopathol. 2014 Dec 8. doi: 10.1002/dc.23239.
    Abstract     Related articles   

  137. NERSESYAN A, Kundi M, Fenech M, Bolognesi C, et al
    Micronucleus assay with urine derived cells (UDC): A review of its application in human studies investigating genotoxin exposure and bladder cancer risk.
    Mutat Res Rev Mutat Res. 2014;762C:37-51.
    Abstract     Related articles   

  138. DEES-RIBBERS HM, Betgen A, Pos FJ, Witteveen T, et al
    Inter- and intra-fractional bladder motion during radiotherapy for bladder cancer: A comparison of full and empty bladders.
    Radiother Oncol. 2014;113:254-9.
    Abstract     Related articles   

  139. MITRAKAS LP, Zachos IV, Tzortzis VP, Gravas SA, et al
    Previous Bladder Cancer History in Patients with High-Risk, Non-muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History.
    Cancer Res Treat. 2014 Sep 11. doi: 10.4143/crt.2014.
    Abstract     Related articles   

  140. PACINI L, De Falco E, Di Bari M, Coccia A, et al
    "M2 Muscarinic Receptors Inhibit Cell Proliferation and Migration in Urothelial Bladder Cancer Cells"
    Cancer Biol Ther. 2014.
    Abstract     Related articles   

  141. SALAS LA, Villanueva CM, Tajuddin SM, Amaral AF, et al
    LINE-1 methylation in granulocyte DNA and trihalomethane exposure is associated with bladder cancer risk.
    Epigenetics. 2014.
    Abstract     Related articles   

  142. GALSKY MD
    How I treat bladder cancer in elderly patients.
    J Geriatr Oncol. 2014 Dec 4. pii: S1879-4068(14)00359.
    Abstract     Related articles   

  143. LEVIN D, Bell S, Sund R, Hartikainen SA, et al
    Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis.
    Diabetologia. 2014.
    Abstract     Related articles   

  144. ZHAO J, Xing N
    Identification of gamma-Synuclein as a Stage-Specific Marker in Bladder Cancer by Immunohistochemistry.
    Med Sci Monit. 2014;20:2550-5.
    Abstract     Related articles   

  145. ZHOU Z, Guo Y, Liu Y, Zhang F, et al
    Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis.
    Exp Cell Res. 2014 Dec 3. pii: S0014-4827(14)00511.
    Abstract     Related articles   

  146. LARCHER A, Sun M, Schiffmann J, Tian Z, et al
    Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
    Eur J Surg Oncol. 2014 Nov 21. pii: S0748-7983(14)01204.
    Abstract     Related articles   

  147. Stromal hedgehog signaling inhibits bladder cancer progression.
    Cancer Discov. 2014;4:OF6.
    Abstract     Related articles   

  148. VON DER EMDE L, Goltz D, Latz S, Muller SC, et al
    Prostaglandin receptors EP1-4 as a potential marker for clinical outcome in urothelial bladder cancer.
    Am J Cancer Res. 2014;4:952-62.
    Abstract     Related articles   

  149. HAO L, Zhang ZG, Han CH, Zhao Y, et al
    Expression of Momordica charantia MAP30 and its anti-tumor effect on bladder cancer cells.
    Minerva Urol Nefrol. 2014.
    Abstract     Related articles   

  150. GRINER EM, Dancik GM, Costello JC, Owens C, et al
    RhoC is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.
    Mol Cancer Res. 2014 Dec 16. pii: molcanres.0420.2014.
    Abstract     Related articles   

  151. RAMMOHAN A, Cherukuri SD, Sathyanesan J, Palaniappan R, et al
    Incidental gall bladder cancers: Are they truly incidental?
    World J Gastrointest Oncol. 2014;6:441-3.
    Abstract     Related articles   

  152. XUE Y, Ma G, Zhang Z, Hua Q, et al
    A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer.
    Oncotarget. 2014.
    Abstract     Related articles   

  153. STONE L
    Bladder cancer: Urinary tract infection increases risk.
    Nat Rev Urol. 2014 Dec 16. doi: 10.1038/nrurol.2014.
    Abstract     Related articles   

  154. FENNER A
    Bladder cancer: Could MPDL3280A offer a therapeutic breakthrough in metastatic bladder cancer?
    Nat Rev Urol. 2014 Dec 16. doi: 10.1038/nrurol.2014.
    Abstract     Related articles   

  155. MA T, Zhang L, Xiao P, Liu Y, et al
    [Clinical significance of CIP2A expression in bladder cancer.]
    Zhonghua Yi Xue Za Zhi. 2014;94:2681-2683.
    Abstract     Related articles   

  156. EISSA S, Habib H, Ali E, Kotb Y, et al
    Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis.
    Med Oncol. 2015;32:413.
    Abstract     Related articles   

  157. TAN WS, Lamb BW, Payne H, Hughes S, et al
    Management of Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy and Radical Cystectomy: A Survey of Current UK Practice.
    Clin Genitourin Cancer. 2014 Nov 20. pii: S1558-7673(14)00257.
    Abstract     Related articles   

  158. SHIRAKAWA R, Horiuchi H
    [Identification of RalGAPs and their downregulation in invasive bladder cancer].
    Seikagaku. 2014;86:671-5.
    Abstract     Related articles   

  159. BAYOUMI Y, Heikal T, Darweish H
    Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients.
    Cancer Manag Res. 2014;6:459-65.
    Abstract     Related articles   

  160. YU Q, Zhang J, Zhang G, Gan Z, et al
    Synthesis and Functions of Well-defined Polymer-drug Conjugates as Efficient Nanocarriers for Intravesical Chemotherapy of Bladder Cancer.
    Macromol Biosci. 2014 Dec 12. doi: 10.1002/mabi.201400416.
    Abstract     Related articles   

  161. BIER S, Sim A, Balbay D, Todenhofer T, et al
    [Treatment of invasive bladder cancer : Robot-assisted radical cystectomy and intracorporeal urinary diversion.]
    Urologe A. 2014.
    Abstract     Related articles   

  162. DONG LM, Zhang XY, Teng H, Li MS, et al
    Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
    Genet Mol Res. 2014;13:9976-85.
    Abstract     Related articles   

  163. WANG HF, Yang H, Hu LB, Lei YH, et al
    Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells.
    Genet Mol Res. 2014;13:9939-50.
    Abstract     Related articles   

  164. OLBERT PJ, Kesch C, Henrici M, Subtil FS, et al
    TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.
    Urol Oncol. 2014 Dec 9. pii: S1078-1439(14)00336.
    Abstract     Related articles   

  165. CARNEIRO BA, Meeks JJ, Kuzel TM, Scaranti M, et al
    Emerging therapeutic targets in bladder cancer.
    Cancer Treat Rev. 2014 Nov 24. pii: S0305-7372(14)00189.
    Abstract     Related articles   

  166. MEDANI S, O'Kelly P, O'Brien KM, Mohan P, et al
    Bladder cancer in renal allograft recipients: risk factors and outcomes.
    Transplant Proc. 2014;46:3466-73.
    Abstract     Related articles   

  167. DU Y, Bi W, Zhang F, Wu W, et al
    G-protein-coupled receptor 137 accelerates proliferation of urinary bladder cancer cells in vitro.
    Biotechnol Appl Biochem. 2014 Dec 11. doi: 10.1002/bab.1329.
    Abstract     Related articles   

  168. XU K, Bagli DJ, Egan SE
    NOTch just a bladder control problem.
    Cancer Cell. 2014;26:452-4.
    Abstract     Related articles   

  169. RAZA SJ, Tawfeeq M, Al-Daghmin A, Guru KA, et al
    Robot-assisted intracorporeal urinary diversion: where do we stand in 2014?
    Urol Clin North Am. 2014;41:503-9.
    Abstract     Related articles   

  170. ALDERMAN M, Kunju LP
    Inflammatory myofibroblastic tumor of the bladder.
    Arch Pathol Lab Med. 2014;138:1272-7.
    Abstract     Related articles   

  171. WU A
    Pseudocarcinomatous hyperplasia of the urinary bladder.
    Arch Pathol Lab Med. 2014;138:1268-71.
    Abstract     Related articles   

  172. MURTAGH K, Kockelbergh R
    Complication of treatment of carcinoma in situ of the bladder with photodynamic targeted cystodiathermy.
    Ann R Coll Surg Engl. 2014;96:e30-1.
    Abstract     Related articles   

    Tumour suppressors: Notch blocks bladder tumorigenesis.
    Nat Rev Cancer. 2014;14.
    Abstract     Related articles   

  174. ZHANG M, Wah C, Epstein JI
    Metastatic renal cell carcinoma to the urinary bladder: a report of 11 cases.
    Am J Surg Pathol. 2014;38:1516-21.
    Abstract     Related articles   

  175. UCHIDA Y, Yoshida S, Kobayashi S, Koga F, et al
    Diffusion-weighted magnetic resonance imaging as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer.
    Br J Radiol. 2014 Jul 30:20130791.
    Abstract     Related articles   

  176. PIATON E, Casalegno JS, Advenier AS, Decaussin-Petrucci M, et al
    p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.
    Cancer Cytopathol. 2014;122:760-9.
    Abstract     Related articles   

  177. KOK HP, Ciampa S, de Kroon-Oldenhof R, Steggerda-Carvalho EJ, et al
    Toward online adaptive hyperthermia treatment planning: correlation between measured and simulated specific absorption rate changes caused by phase steering in patients.
    Int J Radiat Oncol Biol Phys. 2014;90:438-45.
    Abstract     Related articles   

  178. SUISSA S, Azoulay L
    Metformin and cancer: mounting evidence against an association.
    Diabetes Care. 2014;37:1786-8.
    Abstract     Related articles   

  179. PAYTON S
    Basic research: therapeutic action of BCG mediated by H2O2?
    Nat Rev Urol. 2014;11:364.
    Abstract     Related articles   

  180. WALKER NF, Gan C, Olsburgh J, Khan MS, et al
    Diagnosis and management of intradiverticular bladder tumours.
    Nat Rev Urol. 2014;11:383-90.
    Abstract     Related articles   

  181. IBRAHIM AG, Mohammed BS, Aliyu S, Wabada S, et al
    Giant median lobe enlargement of the prostate mimicking advanced bladder tumour: a case report.
    West Afr J Med. 2014;33:74-6.
    Abstract     Related articles   

  182. WANG JM, Wang YQ, Gao ZL, Wu JT, et al
    Expression profiles of variation integration genes in bladder urothelial carcinoma.
    Genet Mol Res. 2014;13:3486-94.
    Abstract     Related articles   

  183. HADDAD-LACLE JE, Haddad CJ, Villas B
    A rare urinary bladder tumour.
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  184. ZHANG H, Qi F, Cao Y, Chen M, et al
    Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis.
    Med Sci Monit. 2014;20:812-7.
    Abstract     Related articles   

  185. KOCA I, Ucar M, Bozdag Z, Alkan S, et al
    Adductor longus muscle metastasis of transitional cell carcinoma of the urinary bladder.
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  186. CHEN CJ, Yen JH, Chang SJ
    Gout patients have an increased risk of developing most cancers, especially urological cancers.
    Scand J Rheumatol. 2014;43:385-90.
    Abstract     Related articles   

  187. MAZONAKIS M, Berris T, Varveris C, Lyraraki E, et al
    Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma.
    Med Phys. 2014;41:051702.
    Abstract     Related articles   

  188. LEON WM, Aw CW, Tran KB
    Lymphomatoid papulosis and recurrent transitional cell carcinoma of the bladder: a paraneoplastic association.
    Dermatol Online J. 2014;20:22369.
    Abstract     Related articles   

  189. CHEN L, Chen C, Liu P, Tang L, et al
    [Significance of digital three-dimensional reconstruction techniques in the diagnosis of pelvic mass].
    Zhonghua Fu Chan Ke Za Zhi. 2014;49:94-9.
    Abstract     Related articles   

  190. KEYMOOSI H, Gheytanchi E, Asgari M, Shariftabrizi A, et al
    ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.
    Asian Pac J Cancer Prev. 2014;15:2013-20.
    Abstract     Related articles   

  191. HARTMANN A, Schlomm T, Bertz S, Heinzelmann J, et al
    [Prognostic and predictive molecular markers for urologic cancers].
    Urologe A. 2014;53:491-500.
    Abstract     Related articles   

  192. RINK M, Soave A, Engel O, Fisch M, et al
    [Tumor cells in the peripheral blood of patients with urothelial carcinoma of the bladder: detection and impact of circulating].
    Urologe A. 2014;53:501-8.
    Abstract     Related articles   

  193. LIN YK, Kaag M, Raman JD
    Rationale and timing of perioperative chemotherapy for upper-tract urothelial carcinoma.
    Expert Rev Anticancer Ther. 2014;14:543-51.
    Abstract     Related articles   

  194. OIKAWA M, Hatakeyama S, Fujita T, Murakami R, et al
    BK Virus-Associated Urothelial Carcinoma of a Ureter Graft in a Renal Transplant Recipient: A Case Report.
    Transplant Proc. 2014;46:616-9.
    Abstract     Related articles   

  195. KARAKIEWICZ PI, Sun M, Azizi M
    Comparative effectiveness of transurethral resection of bladder tumors and office fulguration for recurrent bladder tumors.
    J Comp Eff Res. 2014;3:131-3.
    Abstract     Related articles   

  196. HART PA, Law RJ, Dierkhising RA, Smyrk TC, et al
    Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature.
    Pancreas. 2014;43:417-21.
    Abstract     Related articles   

  197. GUYTON KZ, Hogan KA, Scott CS, Cooper GS, et al
    Human health effects of tetrachloroethylene: key findings and scientific issues.
    Environ Health Perspect. 2014;122:325-34.
    Abstract     Related articles   

  198. DA ROCHA MS, Arnold LL, De Oliveira ML, Catalano SM, et al
    Diuron-induced rat urinary bladder carcinogenesis: mode of action and human relevance evaluations using the International Programme on Chemical Safety framework.
    Crit Rev Toxicol. 2014;44:393-406.
    Abstract     Related articles   

  199. CHATURVEDI N, de Menezes RX, Goeman JJ
    Fused lasso algorithm for Cox' proportional hazards and binomial logit models with application to copy number profiles.
    Biom J. 2014;56:477-92.
    Abstract     Related articles   

  200. SCHEMPP CM, von Schwarzenberg K, Schreiner L, Kubisch R, et al
    V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells.
    Mol Cancer Ther. 2014;13:926-37.
    Abstract     Related articles   

  201. LILJENFELDT L, Dieterich LC, Dimberg A, Mangsbo SM, et al
    CD40L gene therapy tilts the myeloid cell profile and promotes infiltration of activated T lymphocytes.
    Cancer Gene Ther. 2014;21:95-102.
    Abstract     Related articles   

  202. KINGO PS, Hoyer S, Marinovskij E, Rawashdeh YF, et al
    Paediatric urachal benign teratoma: a case report and review of the literature.
    APMIS. 2014;122:761-5.
    Abstract     Related articles   

  203. SHANG C, Zhang H, Guo Y, Hong Y, et al
    MiR-320a down-regulation mediates bladder carcinoma invasion by targeting ITGB3.
    Mol Biol Rep. 2014;41:2521-7.
    Abstract     Related articles   

  204. BOSTON S, Singh A
    Total cystectomy for treatment of transitional cell carcinoma of the urethra and bladder trigone in a dog.
    Vet Surg. 2014;43:294-300.
    Abstract     Related articles   

  205. XYLINAS E, Kluth LA, Lotan Y, Daneshmand S, et al
    Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder.
    Urol Oncol. 2014;32:230-42.
    Abstract     Related articles   

  206. LOPEZ BELTRAN A, Montironi R, Cheng L
    Microcystic urothelial carcinoma: morphology, immunohistochemistry and clinical behaviour.
    Histopathology. 2014;64:872-9.
    Abstract     Related articles   

  207. HELENIUS M, Dahlman P, Magnusson M, Lonnemark M, et al
    Contrast enhancement in bladder tumors examined with CT urography using traditional scan phases.
    Acta Radiol. 2014;55:1129-36.
    Abstract     Related articles   

  208. GUAN F
    Quantitative glycome analysis of N-glycan patterns in bladder cancer vs. normal bladder cells using an integrated strategy.
    J Proteome Res. 2014.
    Abstract     Related articles   

  209. MIREMAMI J, Kyprianou N
    The Promise of Novel Molecular Markers in Bladder Cancer.
    Int J Mol Sci. 2014;15:23897-23908.
    Abstract     Related articles   

    Bladder cancer: Stem cells repopulate tumours.
    Nat Rev Urol. 2014 Dec 23. doi: 10.1038/nrurol.2014.
    Abstract     Related articles   

  211. Urological cancer: Overcoming bladder cancer chemoresistance.
    Nat Rev Clin Oncol. 2014 Dec 23. doi: 10.1038/nrclinonc.2014.
    Abstract     Related articles   

  212. KOBAYASHI T, Owczarek TB, McKiernan JM, Abate-Shen C, et al
    Modelling bladder cancer in mice: opportunities and challenges.
    Nat Rev Cancer. 2014;15:42-54.
    Abstract     Related articles   

  213. KNOWLES MA, Hurst CD
    Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.
    Nat Rev Cancer. 2014;15:25-41.
    Abstract     Related articles   

  214. ZAITSU M, Toyokawa S, Tonooka A, Nakamura F, et al
    Sex differences in bladder cancer pathology and survival: analysis of a population-based cancer registry.
    Cancer Med. 2014 Dec 23. doi: 10.1002.
    Abstract     Related articles   

  215. BRYAN RT
    Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.
    Philos Trans R Soc Lond B Biol Sci. 2015;370.
    Abstract     Related articles   

  216. HUSILLOS ALONSO A, Rodriguez Fernandez E, Herranz Amo F, Lopez Lopez E, et al
    The need for re-TUR of the bladder in non-muscle invasive bladder cancer: risk factors of tumor persistence in re-TUR specimens.
    Minerva Urol Nefrol. 2014;66:233-40.
    Abstract     Related articles   

  217. BEGNINI KR, Moura de Leon PM, Thurow H, Schultze E, et al
    Brazilian red propolis induces apoptosis-like cell death and decreases migration potential in bladder cancer cells.
    Evid Based Complement Alternat Med. 2014;2014:639856.
    Abstract     Related articles   

  218. KAMAT A
    Commentary on "The impact of intravesical gemcitabine and 1/3 dose bacillus Calmette-Guerin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: Results of a prospective, randomized, phase II trial." Gontero
    Urol Oncol. 2015;33:46-7.
    Abstract     Related articles   

  219. KAMAT A
    Commentary on "Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guerin immunotherapy." Lee JY, Diaz RR, Cho KS, Lim MS, Chung JS, Kim WT, Ham WS, Choi
    Urol Oncol. 2015;33:46.
    Abstract     Related articles   

  220. KLOTZ L, Brausi MA
    World Urologic Oncology Federation Bladder Cancer Prevention Program: A global initiative.
    Urol Oncol. 2015;33:25-29.
    Abstract     Related articles   

  221. LIU Y, Lan L, Huang K, Wang R, et al
    Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer.
    Oncotarget. 2014;5:11209-24.
    Abstract     Related articles   

  222. TAIWO OA, Slade MD, Cantley LF, Tessier-Sherman B, et al
    Bladder Cancer Screening in Aluminum Smelter Workers.
    J Occup Environ Med. 2014.
    Abstract     Related articles   

  223. INGELS A, Sanchez Salas RE, Ravery V, Fromont-Hankard G, et al
    T-helper 1 immunoreaction influences survival in muscle-invasive bladder cancer: proof of concept.
    Ecancermedicalscience. 2014;8:486.
    Abstract     Related articles   

  224. FANG Y, Wang Y, Wang Y, Meng Y, et al
    A new tumour suppression mechanism by p27Kip1: EGFR down-regulation mediated by JNK/c-Jun pathway inhibition.
    Biochem J. 2014;463:383-92.
    Abstract     Related articles   

    Bladder cancer: what we can do against this powerful enemy?
    Int Braz J Urol. 2014;40:134-6.
    Abstract     Related articles   

  226. GUO S, Tao X, Wang Y, Tang J, et al
    [SCF/c-Kit signaling promotes invasion of T24 cells via PI3K pathway].
    Nan Fang Yi Ke Da Xue Xue Bao. 2014;34:507-10.
    Abstract     Related articles   

  227. LEOTSAKOS I, Dimopoulos P, Gkioka E, Msaouel P, et al
    Detection of circulating tumor cells in bladder cancer using multiplex PCR assays.
    Anticancer Res. 2014;34:7415-24.
    Abstract     Related articles   

  228. SMITH J, Meng ZW, Lockyer R, Dudderidge T, et al
    Evolution of the Southampton Enhanced Recovery Programme for radical cystectomy and the aggregation of marginal gains.
    BJU Int. 2014;114:375-83.
    Abstract     Related articles   

  229. COLLINS JW, Wiklund NP
    Totally intracorporeal robot-assisted radical cystectomy: optimizing total outcomes.
    BJU Int. 2014;114:326-33.
    Abstract     Related articles   

  230. PALOU J, Hernandez C, Solsona E, ABascal R, et al
    Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study.
    BJU Int. 2014 Dec 15. doi: 10.1111/bju.13020.
    Abstract     Related articles   

  231. HARRAZ AM, Mosbah A, El-Assmy A, Gad H, et al
    Renal function evaluation in patients undergoing orthotopic bladder substitution: a systematic review of literature.
    BJU Int. 2014;114:484-95.
    Abstract     Related articles   

  232. VERMEULEN SH, Hanum N, Grotenhuis AJ, Castano-Vinyals G, et al
    Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study.
    Br J Cancer. 2014 Nov 27. doi: 10.1038/bjc.2014.
    Abstract     Related articles   

  233. ORSOLA A, Werner L, de Torres I, Martin-Doyle W, et al
    Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients.
    Br J Cancer. 2014 Dec 23. doi: 10.1038/bjc.2014.
    Abstract     Related articles   

  234. BASSETT JC, Gore JL, Kwan L, Ritch CR, et al
    Knowledge of the harms of tobacco use among patients with bladder cancer.
    Cancer. 2014 Nov 10. doi: 10.1002/cncr.28915.
    Abstract     Related articles   

  235. CHARLTON ME, Adamo MP, Sun L, Deorah S, et al
    Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: A review of SEER data, 2004-2010.
    Cancer. 2014;120 Suppl S23:3815-3825.
    Abstract     Related articles   

  236. CHANG HY, Liu HS, Lai MD, Tsai YS, et al
    Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON.
    Cancer Res. 2014;74:4549-62.
    Abstract     Related articles   

  237. OSTENFELD MS, Jeppesen DK, Laurberg JR, Boysen AT, et al
    Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties.
    Cancer Res. 2014;74:5758-71.
    Abstract     Related articles   

  238. RIESTER M, Werner L, Bellmunt J, Selvarajah S, et al
    Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.
    Clin Cancer Res. 2014;20:1873-83.
    Abstract     Related articles   

  239. GRECO F, Rassweiler J
    Reply from authors re: M. Pilar Laguna. Are we ready for molecular imaging-guided surgery? Eur Urol 2014;65:965-6: Molecular imaging-guided surgery: a new frontier of urologic surgery?
    Eur Urol. 2014;65:967.
    Abstract     Related articles   

  240. LAGUNA MP
    Are we ready for molecular imaging-guided surgery?
    Eur Urol. 2014;65:965-6.
    Abstract     Related articles   

  241. GRECO F, Cadeddu JA, Gill IS, Kaouk JH, et al
    Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers.
    Eur Urol. 2014;65:947-64.
    Abstract     Related articles   

  242. OOSTERLINCK W, Decaestecker K
    The Correct Sequence of Intravesical Chemotherapy and Bacillus Calmette-Guerin for Non-Muscle-invasive Bladder Cancer.
    Eur Urol. 2014 Nov 26. pii: S0302-2838(14)01210.
    Abstract     Related articles   

  243. MOSTAFID AH, Palou Redorta J, Sylvester R, Witjes JA, et al
    Therapeutic Options in High-risk Non-muscle-invasive Bladder Cancer During the Current Worldwide Shortage of Bacille Calmette-Guerin.
    Eur Urol. 2014 Nov 28. pii: S0302-2838(14)01214.
    Abstract     Related articles   

  244. HOUNSOME LS, Verne J, McGrath JS, Gillatt DA, et al
    Trends in Operative Caseload and Mortality Rates after Radical Cystectomy for Bladder Cancer in England for 1998-2010.
    Eur Urol. 2014 Dec 16. pii: S0302-2838(14)01251.
    Abstract     Related articles   

  245. CHIYOMARU T, Seki N, Inoguchi S, Ishihara T, et al
    Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.
    Int J Oncol. 2014 Nov 14. doi: 10.3892/ijo.2014.2752.
    Abstract     Related articles   

  246. PARK SL, Lee EJ, Kim WJ, Moon SK, et al
    p27KIP1 is involved in ERK1/2-mediated MMP-9 expression via the activation of NF-kappaB binding in the IL-7-induced migration and invasion of 5637 cells.
    Int J Oncol. 2014;44:1349-56.
    Abstract     Related articles   

  247. GANDAGLIA G, Bianchi M, Trinh QD, Becker A, et al
    Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis.
    Int J Urol. 2014;21:249-56.
    Abstract     Related articles   

  248. YAMASHITA R, Matsuzaki M, Niwakawa M, Ito I, et al
    Bacillus Calmette-Guerin treatment of urothelial carcinoma arising in the ileal neobladder after radical cystectomy.
    Int J Urol. 2014;21:333-4.
    Abstract     Related articles   

  249. ELBENDARY M, El-Gamal OM, Tawfik AM, Elbahnasy Ael-H, et al
    Simple modification in Hautmann neobladder to carry out left ureteroileal anastmosis without mobilization of the ureter.
    Int J Urol. 2014;21:413-5.
    Abstract     Related articles   

  250. MACARI D, Faerber GJ, Hafez KS, Hollenbeck BK, et al
    Open surgical partial nephrectomy for upper tract urothelial carcinoma.
    Int J Urol. 2014;21:409-12.
    Abstract     Related articles   

  251. LUO HL, Kang CH, Chen YT, Chuang YC, et al
    Oncological impact of endoscopic bladder cuff management during nephroureterectomy varies according to upper urinary tract tumor location.
    Int J Urol. 2014;21:366-9.
    Abstract     Related articles   

  252. GOU Y, Ding W, Xu K, Wang H, et al
    Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2014.
    Abstract     Related articles   

  253. ZHAO J, Xu W, Zhang Z, Song R, et al
    Prognostic role of HER2 expression in bladder cancer: a systematic review and meta-analysis.
    Int Urol Nephrol. 2014.
    Abstract     Related articles   

  254. RODEL C, Weiss C
    Organ-Sparing Multimodality Treatment for Muscle-Invasive Bladder Cancer: Can We Continue to Ignore the Evidence?
    J Clin Oncol. 2014 Nov 3. pii: JCO.2014.58.5521.
    Abstract     Related articles   

  255. MAK RH, Hunt D, Shipley WU, Efstathiou JA, et al
    Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233.
    J Clin Oncol. 2014 Nov 3. pii: JCO.2014.57.5548.
    Abstract     Related articles   

    Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Are We Asking the Right Questions?
    J Clin Oncol. 2014 Nov 10. pii: JCO.2014.57.3154.
    Abstract     Related articles   

    Neoadjuvant Phase II Studies of Modified Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Cancer.
    J Clin Oncol. 2014 Nov 10. pii: JCO.2014.57.9318.
    Abstract     Related articles   

  258. POUESSEL D, Gauthier H, Serrate C, Pfister C, et al
    Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy in Bladder Cancer: Ready for Prime Time?
    J Clin Oncol. 2014 Nov 10. pii: JCO.2014.58.0498.
    Abstract     Related articles   

  259. DEN OTTER W
    Re: Editorial Comment on Role of Marker Lesion When Applying Intravesical Instillations of IL-2 for Non-Muscle-Invasive Bladder Cancer Comparison of the Therapeutic Effects in Two Pilot Studies: D. P. Wood J Urol 2014; 191: 348.
    J Urol. 2014 Nov 11. pii: S0022-5347(14)04432-2. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

  260. GAYA JM, Lopez-Martinez JM, Karni-Schmidt O, Bonal DM, et al
    DeltaNp63 (DeltaNp63) expression is a protective factor of progression in clinical High Grade T1 bladder cancer.
    J Urol. 2014 Oct 28. pii: S0022-5347(14)04799-5. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

  261. LERNER SP
    Targeted Therapies for Metastatic Bladder Cancer.
    J Urol. 2014 Oct 16. pii: S0022-5347(14)04676-X. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

    Editorial comment.
    J Urol. 2014;192:1077.
    Abstract     Related articles   

  263. SHAH G, Zielonka J, Chen F, Zhang G, et al
    H2O2 generation by bacillus Calmette-Guerin induces the cellular oxidative stress response required for bacillus Calmette-Guerin direct effects on urothelial carcinoma biology.
    J Urol. 2014;192:1238-48.
    Abstract     Related articles   

  264. KATAOKA M, Ishibashi K, Kumagai S, Yanagida T, et al
    Expression and function of lysophosphatidic acid receptor 1 in bladder cancer.
    J Urol. 2014 Dec 15. pii: S0022-5347(14)05080-0. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

  265. WOOD DP
    Re: clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base.
    J Urol. 2015;193:73.
    Abstract     Related articles   

  266. AHMED SM, Wu X, Jin X, Zhang X, et al
    Synergistic induction of apoptosis by mapatumumab and anthracyclines in human bladder cancer cells.
    Oncol Rep. 2014 Dec 5. doi: 10.3892/or.2014.3654.
    Abstract     Related articles   

  267. LI J, Lin B, Li X, Tang X, et al
    Biomarkers for predicting response to tyrosine kinase inhibitors in drug-sensitive and drug-resistant human bladder cancer cells.
    Oncol Rep. 2014 Dec 2. doi: 10.3892/or.2014.3639.
    Abstract     Related articles   

  268. MEYER V, Flechon A, Tartas S, Fassi-Fehri H, et al
    [Impact of neoadjuvant chemotherapy on therapeutic management of muscle-invasive bladder cancer.]
    Prog Urol. 2014 Nov 7. pii: S1166-7087(14)00623.
    Abstract     Related articles   

  269. SCHMITZ-DRAGER BJ, Droller M, Lokeshwar VB, Lotan Y, et al
    Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus.
    Urol Int. 2014.
    Abstract     Related articles   

  270. HEGELE A, Goebell P, Matz U, Neuhaus T, et al
    Monotherapy with intravenous vinflunine in patients with advanced or metastatic urothelial cancer after failure of a platinum-containing regimen: a retrospective analysis of German routine data.
    Urol Int. 2014;92:174-9.
    Abstract     Related articles   

  271. RODRIGUEZ FABA O, Palou J, Breda A, Maroto P, et al
    Predictive factors for impaired renal function following nephroureterectomy in upper urinary tract urothelial cell carcinoma.
    Urol Int. 2014;92:169-73.
    Abstract     Related articles   

  272. TERAKAWA T, Miyake H, Yokoyama N, Miyazaki A, et al
    Clinical outcome of paclitaxel and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with gemcitabine and cisplatin.
    Urol Int. 2014;92:180-5.
    Abstract     Related articles   

  273. SIEMENS DR, Mackillop WJ, Peng Y, Berman D, et al
    Processes of Care and the Impact of Surgical Volumes on Cancer-specific Survival: A Population-based Study in Bladder Cancer.
    Urology. 2014;84:1049-57.
    Abstract     Related articles   

  274. ROGLER A, Hoja S, Giedl J, Ekici AB, et al
    Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.
    BMC Cancer. 2014;14:214.
    Abstract     Related articles   

  275. BONBERG N, Pesch B, Behrens T, Johnen G, et al
    Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study.
    BMC Cancer. 2014;14:854.
    Abstract     Related articles   

  276. ANTONY P, Rose M, Heidenreich A, Knuchel R, et al
    Epigenetic inactivation of ST6GAL1 in human bladder cancer.
    BMC Cancer. 2014;14:901.
    Abstract     Related articles   

  277. VASHISTHA V, Quinn DI, Dorff TB, Daneshmand S, et al
    Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review.
    BMC Cancer. 2014;14:966.
    Abstract     Related articles   

  278. DE CASTRO MARCONDES JP, de Oliveira ML, Gontijo AM, de Camargo JL, et al
    Genetic instability persists in non-neoplastic urothelial cells from patients with a history of urothelial cell carcinoma.
    PLoS One. 2014;9:e86162.
    Abstract     Related articles   

  279. GUO H, Yan D, Wei Y, Han S, et al
    Inhibition of Murine Bladder Cancer Cell Growth In Vitro by Photocontrollable siRNA Based on Upconversion Fluorescent Nanoparticles.
    PLoS One. 2014;9:e112713.
    Abstract     Related articles   

  280. QIU J, Wang X, Meng X, Zheng Y, et al
    Attenuated NER Expressions of XPF and XPC Associated with Smoking Are Involved in the Recurrence of Bladder Cancer.
    PLoS One. 2014;9:e115224.
    Abstract     Related articles   

  281. TABATA K, Matsumoto K, Minami S, Ishii D, et al
    Nestin is an independent predictor of cancer-specific survival after radical cystectomy in patients with urothelial carcinoma of the bladder.
    PLoS One. 2014;9:e91548.
    Abstract     Related articles   

  282. ROPERTO S, Russo V, Borzacchiello G, Urraro C, et al
    Bovine papillomavirus type 2 (BPV-2) E5 oncoprotein binds to the subunit D of the V(1)-ATPase proton pump in naturally occurring urothelial tumors of the urinary bladder of cattle.
    PLoS One. 2014;9:e88860.
    Abstract     Related articles   

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.